Related Articles
Tumor microenvironment manipulates chemoresistance in ovarian cancer (Review)
Advantages of the avian model for human ovarian cancer (Review)
Current data and future perspectives on DNA methylation in ovarian cancer (Review)
Advance in vasculogenic mimicry in ovarian cancer (Review)
SIRT1 and gynecological malignancies (Review)